OrbiMed-backed Theseus debuts with $100M round in heroic quest for 'pan-variant' kinase inhibitors

Kyle Blankenship

Despite the promise of kinase inhibitors in treating rare tumors, narrow therapeutic targets for most candidates can halt efficacy the moment a patient’s tumor cells …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

OrbiMed-backed Theseus debuts with $100M round in heroic quest for 'pan-variant' kinase inhibitors

Kyle Blankenship

Sign up to read this article for free.

FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US vaccine policy

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial

Startup working on oral antibodies shares early ulcerative colitis data

Updated: Lilly joins Trump administration to announce $27B manufacturing commitment

After rejection, Regeneron seeks accelerated approval of bispecific for only one of two types of lymphoma

How AI can address ongoing challenges in the life sciences industry

Or­biMed-backed The­seus de­buts with $100M round in hero­ic quest for 'pan-vari­ant' ki­nase in­hibitors

Kyle Blankenship

Sign up to read this article for free.

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

Kally­ope qui­et­ly re­ports Phase 2 obe­si­ty da­ta, be­gins mid-stage mi­graine tri­al

Start­up work­ing on oral an­ti­bod­ies shares ear­ly ul­cer­a­tive col­i­tis da­ta

Up­dat­ed: Lil­ly joins Trump ad­min­is­tra­tion to an­nounce $27B man­u­fac­tur­ing com­mit­ment

Af­ter re­jec­tion, Re­gen­eron seeks ac­cel­er­at­ed ap­proval of bis­pe­cif­ic for on­ly one of two types of lym­phoma

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

OrbiMed-backed Theseus debuts with $100M round in heroic quest for 'pan-variant' kinase inhibitors

FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US vaccine policy

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial

Startup working on oral antibodies shares early ulcerative colitis data

Updated: Lilly joins Trump administration to announce $27B manufacturing commitment

After rejection, Regeneron seeks accelerated approval of bispecific for only one of two types of lymphoma

How AI can address ongoing challenges in the life sciences industry